HIMS 2-DAY DEADLINE ALERT: Hims & Hers (HIMS) Drops Amid Reported Details of FTC Investigation, Adding To Investor Scrutiny In Pending Securities Class Action – Hagens Berman
SAN FRANCISCO, CA / ACCESS Newswire / August 23, 2025 / Investors who lost money in Hims & Hers (NYSE:HIMS) are being urged to actively participate in a securities class action lawsuit. The lawsuit alleges that Hims made misleading statements about its GLP-1 weight-loss drug business and its partnership with Novo Nordisk, which was abruptly […]